Business
Imugene Licenses Allogeneic CD19 CAR T Cell Therapy
Imugene Licenses Allogeneic CD19 CAR T Cell Therapy
About this update from Imugene Ltd
[{"type":"text","content":"Imugene Ltd has released a press release. View Attachment","length":210,"tagName":"div"}]